Univ. Prof. Dr.med. Martin WERNER
Spezialist für Gefäßkrankheiten

Univ. Prof. Dr. Martin WERNER

Zur Person

Beruflicher Werdegang

Seit 2022
Professor (Univ. Prof.) an der Danube Private University in Krems

Seit 2019
Gastprofessor an der Medizinischen Universität Wien

Seit 2019
Leitung der Angiologie/Gefäßmedizin im Hanusch-Krankenhaus Wien

Seit 2015
Oberarzt am Hanusch-Krankenhaus Wien – Angiologische Abteilung

Habilitation an der Universität Leipzig zum Thema „Interventionelle Techniken zur Steigerung der Effizienz endovaskulärer Verfahren
in der Behandlung arteriosklerotischer Obstruktionen“

Seit 2014
Leitung verschiedener Studien zur kathetergestützten minimal-invasiven Behandlung der PAVK am Hanusch-Krankenhaus Wien

Seit 2013
Facharzt am Hanusch-Krankenhaus Wien
– Angiologische Abteilung

Assistenzarzt und Facharzt in der Klinik für Innere Medizin, Kardiologie und Angiologie, Gefäßzentrum, Parkkrankenhaus Leipzig

Assistenzarzt an der Klinik für Kardiologie, Herzzentrum Leipzig

Doktoratsstudium der Medizinischen Wissenschaften an der Medizinischen Fakultät der Universität Wien, Promotion zum Doktor der Medizinischen Wissenschaften

Wissenschaftliche Tätigkeit und Dissertation am Institut für Pharmakologie der Medizinischen Universität Wien.

Medizinstudium an der Medizinischen Fakultät der Universität Wien, Promotion zum Doktor der gesamten Heilkunde


Intravascular Lithotripsy for Peripheral Artery Calcification: 30-Day Outcomes From the
Tepe G, Brodmann M, Werner M, Bachinsky W, Holden A, Zeller T, Mangalmurti S, Nolte-Ernsting C, Bertolet B, Scheinert D, Gray WA; Disrupt PAD III Investigators.
JACC Cardiovasc Interv. 2021 Jun 28;14(12):1352-1361.

Primary outcomes and mechanism of action of intravascular lithotripsy in calcified, femoropopliteal lesions: Results of Disrupt PAD II. Brodmann M, Werner M, Holden A, Tepe G, Scheinert D, Schwindt A, Wolf F, Jaff M, Lansky A, Zeller T. Catheter Cardiovasc Interv. 2019 Feb 1;93(2):335-342.

Prospective Evaluation of the TIGRIS Vascular Stent Within a Modern Treatment Algorithm.
Werner M, Gomari-Grisar F, Belalcazar S, Hirschl M, Kalchhauser G, Al-Taiee B, Jäger N, Westhausser C, Tischler M, Tischler R. J Endovasc Ther. 2019 Oct;26(5):637-642.

Treating Post-Angioplasty Dissection in the Femoropopliteal Arteries Using the Tack Endovascular System: 12-Month Results From the TOBA II Study.
Gray WA, Cardenas JA, Brodmann M, Werner M, Bernardo NI, George JC, Lansky A.
JACC Cardiovasc Interv. 2019 Dec 9;12(23):2375-2384.

Sustainable Antirestenosis Effect With a Low-Dose Drug-Coated Balloon: The ILLUMENATE European Randomized Clinical Trial 2-Year Results.
Brodmann M, Werner M, Meyer DR, Reimer P, Krüger K, Granada JF, Jaff MR, Schroeder H; ILLUMENATE EU RCT Investigators. JACC Cardiovasc Interv. 2018 Dec 10;11(23):2357-2364

Primary outcomes and mechanism of action of intravascular lithotripsy in calcified, femoropopliteal lesions: Results of Disrupt PAD II. Brodmann M, Werner M, Holden A, Tepe G, Scheinert D, Schwindt A, Wolf F, Jaff M, Lansky A, Zeller T. Catheter Cardiovasc Interv. 2018 Nov 25.

Safety and Performance of Lithoplasty for Treatment of Calcified Peripheral Artery Lesions. Brodmann M, Werner M, Brinton TJ, Illindala U, Lansky A, Jaff MR, Holden A. J Am Coll Cardiol. 2017 Aug 15;70(7):908-910.

ILLUMENATE EU RCT Investigators.. Low-dose Paclitaxel-coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: 1-year Results of the ILLUMENATE European Randomized Clinical Trial. Schroeder H, Werner M, Meyer DR, Reimer P, Krüger K, Jaff MR, Brodmann M; Circulation. 2017 Apr 19.

DES and modern stent technologies for in-stent restenosis. Werner M. , J Cardiovasc Surg (Torino). 2017 Apr 4.

Angioplasty with drug coated balloons for the treatment of infrainguinal peripheral artery disease. Werner M. Vasa. 2016 Sep;45(5):365-72.

Midterm Patency After Femoropopliteal Interventions: A Comparison of Standard and Interwoven Nitinol Stents and Drug-Coated Balloons in a Single-Center, Propensity Score-Matched Analysis. Steiner S, Schmidt A, Bausback Y, Piorkowski M, Werner M, Yahiaoui-Doktor M, Banning-Eichenseer U, Scheinert D. J Endovasc Ther. 2016 Apr;23(2):347-55.

Evaluation of the Biodegradable Igaki-Tamai Scaffold After Drug-Eluting Balloon Treatment of De Novo Superficial Femoral Artery Lesions: The GAIA-DEB Study.. Werner M, Schmidt A, Scheinert S, Banning-Eichenseer U, Ulrich M, Bausback Y, Steiner S, Scheinert D. J Endovasc Ther. 2016 Feb;23(1):92-7

In vitro and in vivo downregulation of the ATP binding cassette transporter B1 by the HMG-CoA reductase inhibitor simvastatin. Atil B, Berger-Sieczkowski E, Bardy J, Werner M, Hohenegger M. Naunyn Schmiedebergs Arch Pharmacol. 2016 Jan;389(1):17-32.

Drug eluting devices for critically ill patients: Can we apply lessons learned from the treatment of peripheral artery disease? Werner M, Scheinert D. Adv Drug Deliv Rev. 2014 Nov 20;77:32-9.

Evaluation of the biodegradable peripheral Igaki-Tamai stent in the treatment of de novo lesions in the superficial femoral artery: GAIA study. Martin Werner, Antonio Micari, Angelo Cioppa, et al. JACC Cardiovasc Interv. 2014 Mar;7(3):305-12.

Treatment of Complex Atherosclerotic Femoropopiteal Artery Disease with a Self-Expanding Interwoven Nitinol Stent. Long-term results from the Leipzig Supera-500 Registry. Martin Werner, Anett Paetzold, Ursula Banning-Eichenseer, et al. EuroIntervention. 2014 Mar 31

Late open conversion after endovascular aneurysm repair. Interact Cardiovasc Thorac Surg. 2014 Jun 24. Botsios S, Bausback Y, Piorkowski M, Werner M, Branzan D, Scheinert D, Schmidt A.

Renal denervation for hypertension refractory to renal artery stenting. J Endovasc Ther. 2014 Apr;21(2):181-90. Bausback Y, Friedenberger J, Hertting K, Werner M, Branzan D, Freitas B, Piorkowski M, Schmidt A, Scheinert D.

The SUMMIT registry: One-year outcomes after implantation of the EPIC Self- Expanding Nitinol Vascular Stent in the femoro-popliteal artery. Martin Werner, Michael Piorkowski, Markus Thieme, et al. J Endovasc Ther. 2013;20:759–766

Bifurcation stenting after failed angioplasty of infrapopliteal arteries in chronic limb ischemia: Techniques and short-term follow-up. Martin Werner, Susanne Scheinert, Yvonne Bausback et al. Catheter Cardiovasc Interv. 2013 Oct 1;82(4):E522-8. doi:10.1002/ccd.24828. Epub 2013 Mar 8.

Simvastatin-induced compartmentalisation of doxorubicin sharpens up nuclear topoisomerase II inhibition in human rhabdomyosarcoma cells. Werner M, Atil B, Sieczkowski E, et al. Naunyn Schmiedebergs Arch Pharmacol. 2013 Jul;386(7):605-17.

First clinical experience with the GARDEX EPD: a novel embolic protection device for carotid artery stenting. Martin Werner, Dierk Scheinert, Borghesi R et al. EuroIntervention. 2013 Jan 22;8(9):1026-32.

The use of the GORE TIGRIS Vascular Stent with dual component design in the superficial femoral and popliteal arteries at 6 months. J Cardiovasc Surg (Torino). 2013 Aug;54(4):447-53. Piorkowski M, Freitas B, Schmidt A, Bräunlich S, Ulrich M, Schuster J, Bausback Y, Werner M, Scheinert D.

Treatment of complex atherosclerotic popliteal artery disease with a new self-expanding interwoven nitinol stent: 12-month results of the Leipzig SUPERA popliteal artery stent registry. Scheinert D, Werner M, Scheinert S, Paetzold A, Banning-Eichenseer U, Piorkowski M, Ulrich M, Bausback Y, Bräunlich S, Schmidt A. JACC Cardiovasc Interv. 2013 Jan;6(1):65-71.

Techniques and outcome of retrograde crural artery revascularization. Martin Werner, Michael Piorkowski, Andrej Schmidt. J Cardiovasc Surg (Torino). 2013 Feb;54(1 Suppl 1):151-8.

Endovascular liquid rhenium-188 beta-brachytherapy for the treatment of long-segment femoropopliteal in-stent stenosis. Martin Werner, Dierk Scheinert, Marcela Henn et al. J Endovasc Ther. 2012 Aug;19(4):467-75.

Anatomic variables contributing to a higher periprocedural incidence of stroke and TIA in carotid artery stenting: Single center experience of 833 consecutive cases. Martin Werner, Yvonne Bausback, Sven Bräunlich et al. Catheter Cardiovasc Interv. 2012 Aug 1;80(2):321-8.

Sirolimus eluting stents for the treatment of infrapopliteal arteries in chronic limb ischemia: Clinical and angiographical long-term follow-up. Martin Werner, Andrej Schmidt, Michael Freyer et al. J Endovasc Ther 2012;19:12–19.

European registry of carotid artery stenting: Results from a prospective registry of eight high volume european institutions. Stabile E, Pallav G, Cremonesi A, Bosiers M, Reimers B, Setacci C, Cao P, Schmidt A, Sievert H, Peeters P, Nikas D, Werner M, de Donato G, Parlani G, Castriota F, Hornung M, Mauri L, Rubino P. Catheter Cardiovasc Interv. 2012 May 3. doi: 10.1002/ccd.24348.

Retrograde recanalization technique for use after failed antegrade angioplasty in chronic femoral artery occlusions. Schmidt A, Bausback Y, Piorkowski M, Werner M, Bräunlich S, Ulrich M, Varcoe R, Friedenberger J, Schuster J, Botsios S, Scheinert D. J Endovasc Ther. 2012 Feb;19(1):23-9.

A novel self-expanding interwoven nitinol stent for complex femoropopliteal lesions: 24-month results of the SUPERA SFA registry. Scheinert D, Grummt L, Piorkowski M, Sax J, Scheinert S, Ulrich M, Werner M, Bausback Y, Braunlich S, Schmidt A. J Endovasc Ther. 2011 Dec;18(6):745-52.

First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. Schmidt A, Piorkowski M, Werner M, Ulrich M, Bausback Y, Bräunlich S, Ick H, Schuster J, Botsios S, Kruse HJ, Varcoe RL, Scheinert D. J Am Coll Cardiol. 2011 Sep 6;58(11):1105-9.

Outback catheter for femoropopliteal occlusions: immediate and long-term results. Bausback Y, Botsios S, Flux J, Werner M, Schuster J, Aithal J, Varcoe R, Bräunlich S, Ulrich M, Scheinert D, Schmidt A. J Endovasc Ther. 2011 Feb;18(1):13-21.

Delineation of myotoxicity induced by 3-hydroxy-3-methylglutaryl CoA reductase inhibitors in human skeletal muscle cells. J Pharmacol Exp Ther. 2005 Sep;314(3):1032-41. Sacher J, Weigl L, Werner M, Szegedi C, Hohenegger M.

Mutual amplification of apoptosis by statin induced mitochondrial stress and doxorubicin toxicity in human rhabdomyosarcoma cells. Martin Werner, Julia Sacher, Martin Hohenegger. Br J Pharmacol. 2004; 143, 715-724

Vorträge und Präsentationen


Shunt-Ultraschall Masterclass – Tutor am 3. Österreichisches Symposium über Dialysezugänge


Kongressleitung Kardiovaskuläres Symposium Wilheminenberg 01/20

Wie kann ich das Outcome der BTK Intervention verbessern? – DGA Kongress Kempten 09/20


PAVK – Leitlinien und klinischer Alltag – Kardiovaskuläres Symposium Wilheminenberg 01/19

Results of the Austrian TIGRIS Registry– Leipzig Interventional Course 01/19

Retrograde Recanalization – Leipzig Interventional Course 01/19


Results of the Austrian Tigris Registry 11/18 New York VEITH Symposium


PAVK – Leitlinien und klinischer Alltag – Kardiovaskuläres Symposium Wilheminenberg 01/17

Outcome of femoropoliteal procedures in diabetic patients – Leipzig Interventional Course 01/17

Fracture Resistance of the TIGRIS stents – Leipzig Interventional Course 01/17

Aktuelle Aspekte bei cerebraler AVK – Lange Nacht der Angiologie 03/17

How the unique features of the vascular stent relate to optimal clinical outcomes – Charing Cross Conference, London, 04/17

DCB plus Stent: Combination therapy – A concept of the future!? – ESVM meeting, Graz 05/17

Atherectomy in the BTK arteries– I-Meet, Nizza 06/17


Supera Stent Tipps und Tricks – IROS Kongress Salzburg 01/2016

Akute Ischämie – Kardiovaskuläres Symposium Wilheminenberg 01/16

Step by step: Infrapopliteal revascularization – Leipzig Interventional Course 01/16

Supera Stent Complex Case Presentation – LINC Dubai 04/16

The evidence: Are bare technologies obsolete? – LINC Dubai 2016 04/16

Scaffolding with or without drugs below the knee – I-Meet Nizza 06/16

DCB technology and evidence appraisal: The no-class-effect explained – DGG Dreiländertagung Bern 10/16

Improving Patency of Infrapopliteal Interventions: The Role of DCB, DES, and BVS – VIVA Conference Las Vegas 09/16

1 year results of the Illumenate EU Trial – TCT Washington DC 11/16


Perspectives, December 2015, Bordeaux, Retrograde Recanalization below the knee – state of the art

Biotronik Excellence Circle 2015, November 2015, Wien, Kann DCB als Therapieoption Nr. 1 bezeichnet werden?

VIVA 2015 – Vascular Interventional Advances, November 2015, Las Vegas, Balloon Technologies for Below-the-Knee Disease, Atherectomy With or Without DCB: Is There a Role? The Use of Advanced Crossing Devices and Revascularization Tools BTK

16. Unionstagung der Schweizerischen Gesellschaften für Gefäßmedizin, Oktober 2015, Evidenzbasierte Kathetermedizin

VASCMED Innsbruck, Oktober 2015, SUPERA Stent im femoropoplitealen segment: Fallpräsentationen, Tipps und Tricks

31. Jahrestagung der Deutschen Gesellschaft für Gefäßchirurgie und Gefäßmedizin, Münster, September 2015, The „Shockwave lithoplasty“ Konzept: haben wir die endgültige Lösung für die kalzifizierten Läsionen? Bewährt: Passeo-Lux DCB Technologie.

Angiologische Sommerakademie Baden, Mai 2015, CTO devices – ersetzen sie die Chirurgie? SUPERA Stent für die femoropopliteale Strombahn Fallpräsentationen, Tipps und Tricks

1st annual ESVM congress, Mai 2015, Potsdam, Puncture techniques

Leipzig Interventional Course – LINC 2015 – Balloon, DCB or stent? What is standard of interventional treatment in the popliteal artery?
1 year results of the Gore TIGRIS vascular stent in femoropopliteal lesions

11. Kardiovaskuläres Symposium, Jänner 2015, Wien – Schloß Wilhelminenberg Von der Diagnose zur Therapie der PAVK


Jahrestagung der österreichischen Gesellschaft für internistische Angiologie, Oktober 2014, Innsbruck – ABI-Messung – sinnvoll oder verzichtbar?

Jahrestagung der deutschen Gesellschaft für Angiologie, September 2014, Hamburg – Bioresorbierbare Stents in der Behandlung der PAVK

Leipzig Interventional Course – LINC 2014 – Pedal puncture and other retrograde recanalization techniques; Medical therapy after angioplasty / stenting


Belgian Young Flowmaster Meeting – November 2013, Brussels – Contra-indicated thrombolysis case: quid alternative?

VIVA 2013 – Vascular Interventional Advances, October 2013, Las Vegas – Basic and Specialty Balloons, DCBs; The European Union Approach to CLI

Charing Cross International Symposium, April 2013, Imperial College, London, UK – Optimal solutions for the popliteal artery

Leipzig Interventional Course – LINC 2013 – The SUMMIT study: 12 months results with the EPIC stent in the SFA


Munich Vascular Conference (MVC) – December 2012 – Technologies and techniques to avoid embolism during CA S

Belgian Young Flowmaster Meeting – National symposium on diabetic foot – November 2012, Brussels – Wire Based Techniques:
How best to incorporate different wire technologies and micro catheters to achieve success?

National Conference of the Vascular Society of India September 2012, Ram Bagh Palace, Jaipur, India

Frühjahrstagung Herzzentrum Leipzig, Mai 2012 – Der akute Gefäßverschluß

Charing Cross International Symposium, April 2012, Imperial College, London, UK – Optimal solutions for the popliteal artery

Leipzig Interventional course – LINC 2012 – GAIA-DEB study – 6 months data and The Leipzig SUPERA popliteal stent registry: 12 months data


Belgian Young Flowmaster Meeting – National symposium on diabetic foot – November 2011 – Angioplasty Of Complex Infrainguinal Lesions

3èmes Jourenées Scientifiques Internationales Gelev Maroc – May 2011 – Atherectomy by Laser

Frühjahrstagung Herzzentrum Leipzig, Mai 2011- Arterielle Verschlußssysteme

Charing Cross International Symposium April 2011, Imperial College, London, UK – Optimal carotid stenting technique – patient specific approaches

Annual meeting of the Belgian Society for Vascular Surgery March 2011 – Angioplasty Of Complex Lesions Below The Knee

Leipzig Interventional Course – LINC 2011 – Patient specific risk factors for neurological complications during Carotid Artery Stenting


3. Viersener Kardiologie Symposium 2010 – Neues in der Behandlung femoropoplitealer Stenosen und Verschlüsse